Immunic, Inc.

Ownership Transactions Reported by 13 Insiders

Symbol
IMUX on Nasdaq
Industry
Pharmaceutical Preparations
Location
1200 Avenue Of The Americas, Suite 200, New York, US

Insiders trading volume in the past year

Immunic, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Daniel Vitt CEO and Director, Director $512K +$18.3K +3.71% Dec 4, 2024
Richard Rudick Director $100K +$100K Nov 12, 2024
Barclay Phillips Director Jun 11, 2024
Duane Nash Executive Chairman, Director Dec 4, 2024
Jan van den Bossche Director Jun 15, 2022
Joerg Neermann Director Jun 11, 2024
Glenn Whaley Chief Financial Officer Dec 4, 2024
Andreas Muehler Chief Medical Officer Dec 4, 2024
Monika Maria Toernsen Director Jun 11, 2024
Tamar Howson Director Jun 11, 2024
Simona Skerjanec Director Jul 22, 2024
Vincent Ossipow Director Jun 15, 2022
Jason Tardio President and COO Dec 4, 2024

Recent Insider Transactions by Companies or Individuals for Immunic, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.